Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeni-Komshian, H.
Right arrow Articles by Reaven, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeni-Komshian, H.
Right arrow Articles by Reaven, G. M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 23, Issue 2 171-175, Copyright © 2000 by American Diabetes Association

ARTICLES

Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers

H Yeni-Komshian, M Carantoni, F Abbasi and GM Reaven
Stanford University School of Medicine, California, USA.

OBJECTIVE: The goal of this study was to define the relationship between a quantitative measure of the ability of physiological hyperinsulinemia to stimulate glucose disposal and several surrogate measures of insulin resistance. RESEARCH DESIGN AND METHODS: Insulin-mediated glucose disposal was quantified in 490 healthy nondiabetic volunteers by determining the steady-state plasma glucose (SSPG) concentration in response to a continuous infusion of somatostatin, insulin, and glucose. Because the steady-state plasma insulin concentration was similar in all subjects during the infusion (approximately 60 microU/ml), the SSPG concentration provided a direct estimate of insulin-mediated glucose disposal. Relationships between this specific measure of insulin resistance and several surrogate estimates of insulin resistance based on plasma glucose and insulin concentrations were then defined. RESULTS: The surrogate measure of insulin resistance most closely related to the direct determination of insulin action was the total integrated insulin response to a 75-g oral glucose challenge with correlation coefficients (r) varying from 0.67 to 0.79. Fasting plasma insulin concentration was significantly correlated (r = 0.61, P<0.001) to the specific estimate of insulin action. Two other surrogate estimates of insulin action, the ratio of fasting glucose-to-fasting insulin concentration and the homeostasis model assessment for insulin resistance, were no more closely related to SSPG than the fasting plasma insulin concentration. CONCLUSIONS: The total integrated insulin response to oral glucose is the best surrogate measure of insulin resistance, accounting for approximately two-thirds of the variability in insulin-mediated glucose disposal. Fasting insulin concentration accounted for approximately one-third of the variability in insulin-mediated glucose disposal, and the use of fasting plasma glucose and insulin concentrations to calculate more sophisticated estimates of insulin resistance appears to offer little advantage over the fasting plasma insulin concentration. Given the large number of nondiabetic individuals in this study, the results should have general application in population-based studies, providing evidence for both the utility and limitation of the use of these surrogate measures.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
S. H. Kim and G. M. Reaven
Insulin Resistance and Hyperinsulinemia: You can't have one without the other
Diabetes Care, July 1, 2008; 31(7): 1433 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Martin, L. P. Palaniappan, A. C. Kwan, G. M. Reaven, and P. D. Reaven
Ethnic Differences in the Relationship Between Adiponectin and Insulin Sensitivity in South Asian and Caucasian Women
Diabetes Care, April 1, 2008; 31(4): 798 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
I. D. Goldfine, B. A. Maddux, J. F. Youngren, G. Reaven, D. Accili, V. Trischitta, R. Vigneri, and L. Frittitta
The Role of Membrane Glycoprotein Plasma Cell Antigen 1/Ectonucleotide Pyrophosphatase Phosphodiesterase 1 in the Pathogenesis of Insulin Resistance and Related Abnormalities
Endocr. Rev., February 1, 2008; 29(1): 62 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. H. Kim and G. M. Reaven
Isolated Impaired Fasting Glucose and Peripheral Insulin Sensitivity: Not a simple relationship
Diabetes Care, February 1, 2008; 31(2): 347 - 352.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Muniyappa, S. Lee, H. Chen, and M. J. Quon
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E15 - E26.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Y.-X. Meng, E. S. Ford, C. Li, A. Quarshie, A. M. Al-Mahmoud, W. Giles, G. H. Gibbons, and G. Strayhorn
Association of C-Reactive Protein with Surrogate Measures of Insulin Resistance among Nondiabetic US Adults: Findings from National Health and Nutrition Examination Survey 1999 2002
Clin. Chem., December 1, 2007; 53(12): 2152 - 2159.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. Vigil, P. Contreras, J. L. Alvarado, A. Godoy, A. M. Salgado, and M. E. Cortes
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome
Hum. Reprod., November 1, 2007; 22(11): 2974 - 2980.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. F. Crutchlow, B. Robinson, B. Pappachen, N. Wimmer, A. J. Cucchiara, D. Cohen, and R. Townsend
Validation of Steady-State Insulin Sensitivity Indices in Chronic Kidney Disease
Diabetes Care, July 1, 2007; 30(7): 1813 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Li and E. S. Ford
Is There a Single Underlying Factor for the Metabolic Syndrome in Adolescents?: A confirmatory factor analysis
Diabetes Care, June 1, 2007; 30(6): 1556 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Beysen, E. J. Murphy, T. McLaughlin, T. Riiff, C. Lamendola, H. C. Turner, M. Awada, S. M. Turner, G. Reaven, and M. K. Hellerstein
Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo
Diabetes Care, May 1, 2007; 30(5): 1143 - 1149.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. C. Ryan, F. Abbasi, C. Lamendola, S. Carter, and T. L. McLaughlin
Serum Alanine Aminotransferase Levels Decrease Further With Carbohydrate Than Fat Restriction in Insulin-Resistant Adults
Diabetes Care, May 1, 2007; 30(5): 1075 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
T. McLaughlin, F. Abbasi, C. Lamendola, and G. Reaven
Heterogeneity in the Prevalence of Risk Factors for Cardiovascular Disease and Type 2 Diabetes Mellitus in Obese Individuals: Effect of Differences in Insulin Sensitivity
Arch Intern Med, April 9, 2007; 167(7): 642 - 648.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Abbasi, H. M. F. Farin, C. Lamendola, T. McLaughlin, E. A. Schwartz, G. M. Reaven, and P. D. Reaven
The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5002 - 5007.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. N. A. Black, M. Spence, R. O. McMahon, G. J. Cuskelly, C. N. Ennis, D. R. McCance, I. S. Young, P. M. Bell, and S. J. Hunter
Effect of Eucaloric High- and Low-Sucrose Diets With Identical Macronutrient Profile on Insulin Resistance and Vascular Risk: A Randomized Controlled Trial
Diabetes, December 1, 2006; 55(12): 3566 - 3572.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven
Trends in hyperinsulinemia among nondiabetic adults in the u.s.
Diabetes Care, November 1, 2006; 29(11): 2396 - 2402.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
T. McLaughlin, S. Carter, C. Lamendola, F. Abbasi, G. Yee, P. Schaaf, M. Basina, and G. Reaven
Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 813 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
G. M Reaven
The metabolic syndrome: is this diagnosis necessary?
Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. McLaughlin, M. Stuhlinger, C. Lamendola, F. Abbasi, J. Bialek, G. M. Reaven, and P. S. Tsao
Plasma Asymmetric Dimethylarginine Concentrations Are Elevated in Obese Insulin-Resistant Women and Fall with Weight Loss
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1896 - 1900.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
H. M. Farin, F. Abbasi, and G. M Reaven
Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults
Am. J. Clinical Nutrition, January 1, 2006; 83(1): 47 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Abbasi, S.-A. Chang, J. W. Chu, T. P. Ciaraldi, C. Lamendola, T. McLaughlin, G. M. Reaven, and P. D. Reaven
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R139 - R144.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. A. Cataldo, F. Abbasi, T. L. McLaughlin, M. Basina, P. Y. Fechner, L. C. Giudice, and G. M. Reaven
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome
Hum. Reprod., January 1, 2006; 21(1): 109 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kahn, J. Buse, E. Ferrannini, and M. Stern
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care, September 1, 2005; 28(9): 2289 - 2304.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. H. Kim, F. Abbasi, J. W. Chu, T. L. McLaughlin, C. Lamendola, K. S. Polonsky, and G. M. Reaven
Rosiglitazone Reduces Glucose-Stimulated Insulin Secretion Rate and Increases Insulin Clearance in Nondiabetic, Insulin-Resistant Individuals
Diabetes, August 1, 2005; 54(8): 2447 - 2452.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
S. Craft
Insulin Resistance and Cognitive Impairment: A View Through the Prism of Epidemiology
Arch Neurol, July 1, 2005; 62(7): 1043 - 1044.
[Full Text] [PDF]

Home page
 Vasc MedHome page
K. Sydow, C. E Mondon, and J. P Cooke
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
Vascular Medicine, July 1, 2005; 10(1_suppl): S35 - S43.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
G. M. Reaven
The Metabolic Syndrome: Requiescat in Pace
Clin. Chem., June 1, 2005; 51(6): 931 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
K. Sydow, C. E Mondon, and J. P Cooke
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
Vascular Medicine, May 1, 2005; 10(2_suppl): S35 - S43.
[Abstract] [PDF]

Home page
 DiabetesHome page
N. Abate, M. Chandalia, P. Satija, B. Adams-Huet, S. M. Grundy, S. Sandeep, V. Radha, R. Deepa, and V. Mohan
ENPP1/PC-1 K121Q Polymorphism and Genetic Susceptibility to Type 2 Diabetes
Diabetes, April 1, 2005; 54(4): 1207 - 1213.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
V. Sepilian and M. Nagamani
Adiponectin Levels in Women With Polycystic Ovary Syndrome and Severe Insulin Resistance
Reproductive Sciences, February 1, 2005; 12(2): 129 - 134.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Sepilian and M. Nagamani
Effects of Rosiglitazone in Obese Women with Polycystic Ovary Syndrome and Severe Insulin Resistance
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 60 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. H. Kim, F. Abbasi, and G. M. Reaven
Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance
Diabetes Care, August 1, 2004; 27(8): 1998 - 2002.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. M. Witteles, W. H. W. Tang, A. H. Jamali, J. W. Chu, G. M. Reaven, and M. B. Fowler
Insulin resistance in idiopathic dilated cardiomyopathy: A possible etiologic link
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 78 - 81.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-Johnsen, and K. Pyorala
Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
Arch Intern Med, May 24, 2004; 164(10): 1066 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. L. Cheal, F. Abbasi, C. Lamendola, T. McLaughlin, G. M. Reaven, and E. S. Ford
Relationship to Insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic Syndrome
Diabetes, May 1, 2004; 53(5): 1195 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. McLaughlin, F. Abbasi, C. Lamendola, R. S. Frayo, and D. E. Cummings
Plasma Ghrelin Concentrations Are Decreased in Insulin-Resistant Obese Adults Relative to Equally Obese Insulin-Sensitive Controls
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1630 - 1635.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. M. Reaven
Insulin Resistance, Cardiovascular Disease, and the Metabolic Syndrome: How well do the emperor's clothes fit?
Diabetes Care, April 1, 2004; 27(4): 1011 - 1012.
[Full Text] [PDF]

Home page
 DiabetesHome page
F. Abbasi, J. W. Chu, C. Lamendola, T. McLaughlin, J. Hayden, G. M. Reaven, and P. D. Reaven
Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin
Diabetes, March 1, 2004; 53(3): 585 - 590.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. E. Kasim-Karakas, R. U. Almario, L. Gregory, R. Wong, H. Todd, and B. L. Lasley
Metabolic and Endocrine Effects of a Polyunsaturated Fatty Acid-Rich Diet in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 615 - 620.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, and G. Reaven
Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant
Ann Intern Med, November 18, 2003; 139(10): 802 - 809.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Farnsworth, N. D Luscombe, M. Noakes, G. Wittert, E. Argyiou, and P. M Clifton
Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women
Am. J. Clinical Nutrition, July 1, 2003; 78(1): 31 - 39.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. M. Reaven
Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2399 - 2403.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. W. Chu, F. Abbasi, K. R. Kulkarni, C. Lamendola, T. L. McLaughlin, J. N. Scalisi, and G. M. Reaven
Multiple Lipoprotein Abnormalities Associated with Insulin Resistance in Healthy Volunteers Are Identified by the Vertical Auto Profile-II Methodology
Clin. Chem., June 1, 2003; 49(6): 1014 - 1017.
[Full Text] [PDF]

Home page
 NeurologyHome page
W. N. Kernan, S. E. Inzucchi, C. M. Viscoli, L. M. Brass, D. M. Bravata, G. I. Shulman, J. C. McVeety, and R. I. Horwitz
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
Neurology, May 13, 2003; 60(9): 1447 - 1451.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Allard, E. E. Delvin, G. Paradis, J. A. Hanley, J. O'Loughlin, C. Lavallee, E. Levy, and M. Lambert
Distribution of Fasting Plasma Insulin, Free Fatty Acids, and Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents
Clin. Chem., April 1, 2003; 49(4): 644 - 649.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. T. Tran, N. Gupta, T. Goh, D. Naigamwalla, M. C. Chia, N. Koohestani, S. Mehrotra, G. McKeown-Eyssen, A. Giacca, and W. R. Bruce
Direct Measure of Insulin Sensitivity with the Hyperinsulinemic-Euglycemic Clamp and Surrogate Measures of Insulin Sensitivity with the Oral Glucose Tolerance Test: Correlations with Aberrant Crypt Foci Promotion in Rats
Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 47 - 56.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. McLaughlin, F. Abbasi, C. Lamendola, L. Liang, G. Reaven, P. Schaaf, and P. Reaven
Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein
Circulation, December 3, 2002; 106(23): 2908 - 2912.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
H. S Kahn and R. Valdez
Fatty acid composition of abdominal adipose tissue
Am. J. Clinical Nutrition, June 1, 2002; 75(6): 1123 - 1123.
[Full Text] [PDF]

Home page
 JAMAHome page
M. C. Stuhlinger, F. Abbasi, J. W. Chu, C. Lamendola, T. L. McLaughlin, J. P. Cooke, G. M. Reaven, and P. S. Tsao
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
JAMA, March 20, 2002; 287(11): 1420 - 1426.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. J. Mather, A. E. Hunt, H. O. Steinberg, G. Paradisi, G. Hook, A. Katz, M. J. Quon, and A. D. Baron
Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5457 - 5464.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Ceolotto, R. Valente, E. Baritono, S. Reato, E. Iori, A. Monari, R. Trevisan, and A. Semplicini
Effect of Insulin and Angiotensin II on Cell Calcium in Human Skin Fibroblasts
Hypertension, June 1, 2001; 37(6): 1486 - 1491.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. J. Hasstedt, Q.-F. Ren, K. Teng, and S. C. Elbein
Effect of the Peroxisome Proliferator-Activated Receptor-{{gamma}}2 Pro12Ala Variant on Obesity, Glucose Homeostasis, and Blood Pressure in Members of Familial Type 2 Diabetic Kindreds
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 536 - 541.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
C. M. Ferrara and A. P. Goldberg
Limited Value of the Homeostasis Model Assessment to Predict Insulin Resistance in Older Men With Impaired Glucose Tolerance
Diabetes Care, February 1, 2001; 24(2): 245 - 249.
[Abstract] [Full Text]

Home page
 Exp. Biol. Med.Home page
W. T. Cefalu
Insulin Resistance: Cellular and Clinical Concepts
Experimental Biology and Medicine, January 1, 2001; 226(1): 13 - 26.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Ai, A. Tanaka, K. Ogita, M. Sekine, F. Numano, F. Numano, and G. M. Reaven
Relationship between Hyperinsulinemia and Remnant Lipoprotein Concentrations in Patients with Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3557 - 3560.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.